GlassScriptPhysician profile
Jennifer Balint
NPI 1417478025
$821.48
in general payments reported to CMS, 2019-2025
19 companies · $528 in 2025
The $528 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $294 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $821.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $241.70 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Abbott Laboratories | $68.57 | 2024 | Amplatzer Amulet |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.75 | 2024-2025 | Jardiance |
| Corcept Therapeutics | $48.68 | 2024-2025 | Korlym |
| Boston Scientific Corporation | $47.94 | 2025 | Watchman Flx |
| Pfizer INC. | $41.64 | 2025 | |
| Novo Nordisk INC | $41.55 | 2025 | |
| Glaxosmithkline, LLC. | $34.91 | 2025 | Arexvy, Shingrix |
| Actelion Pharmaceuticals US, INC. | $32.46 | 2024-2025 | Opsumit, Uptravi |
| Lilly USA, LLC | $30.89 | 2024-2025 | Mounjaro, Zepbound |
| Rhythm Pharmaceuticals, INC. | $25.78 | 2025 | Imcivree |
| Merck Sharp & Dohme LLC | $24.72 | 2024 | Vaxelis, Gardasil, Gardasil 9 |
| Medicomp INC | $23.70 | 2025 | Telepatch Cardiac Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $22.50 | 2024 | |
| Amgen INC. | $19.81 | 2025 | Repatha, Otezla |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $18.67 | 2025 | Rexulti |
| Exact Sciences Corporation | $17.90 | 2024 | Cologuard Collection Kit |
| Shield Therapeutics INC | $16.53 | 2024 | |
| Cequr Corporation | $12.78 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Balint listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.